People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Biotechnology, Business Services
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Montara Therapeutics, Inc. | — | Biotechnology | Series B | $28.0M | $107.6M | 2025 |
| Horsetail Technologies, LLC | — | Business Services | Series A | $7.1M | $22.6M | 2022 |
Zachary Hill at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Zachary Hill on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| TROY WILSON | 1 | 7 |
| Dave Adams | 1 | 2 |
| Nicholas Hertz | 1 | 2 |
| Rishi Rakhit | 1 | 1 |
| Randall Chin | 1 | 1 |
| Dirk Langdorf | 1 | 1 |
| Christopher Sachse | 1 | 1 |
| Max Lebovitz | 1 | 1 |
| Travis Sachse | 1 | 1 |
| Patricia Campbell | 1 | 1 |
| Andrea DiGiacomo | 1 | 1 |
| Eufemia M Solorzano | 1 | 1 |
| Michael Mattews | 1 | 1 |
| Chris Sachse | 1 | 1 |
| Seth Stratton | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.